Model‐informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma

por Savic, Radojka M., Green, Michelle L., Jorga, Karin, Zager, Michael, Washington, Carla B.
Publicado 2022

Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action

por Green, Michelle L., Savic, Radojka M., Tonda, Margaret, Jorga, Karin, Washington, Carla B.
Publicado 2022